Stock 603567 HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Heilongjiang ZBD Pharmaceutical Co., Ltd.

Equities

603567

CNE100002219

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 20/05/2024 am IST 		5-day change 1st Jan Change
13 CNY +1.72% Intraday chart for Heilongjiang ZBD Pharmaceutical Co., Ltd. +6.91% +6.91%
07/05 China Grants Drug Registration Approval for ZBD Pharma's Anti-Epilepsy Injectable MT
29/04 Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

HeiLongJiang ZBD Pharmaceutical Co., Ltd. is a China-based pharmaceutical company engaged in the research and development, manufacture and sales of Chinese patent medicine. The Company's products include freeze-dried powder injections, powder injections, large volume injections, small volume injections, mixture, tablets, capsule, granules, syrup, oral solution, decoction agent and active pharmaceutical ingredient, which are used for the areas of cardiovascular, anti-viral flu, fracture and osteoporosis, immune enhancement and liver protection. The Company distributes its products under the brand named Zhenbaodao.

Number of employees: 2,760

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Medicine Preparations
51.1 %
872 20.7 % 1,604 51.1 % +84.06%
Traditional Chinese MedicineTrade
25.3 %
2,806 66.6 % 795 25.3 % -71.68%
Chemical Preparations
11.0 %
122 2.9 % 347 11.0 % +184.10%
Pharmaceutical Trade
9.8 %
320 7.6 % 308 9.8 % -3.92%
Other Business
1.7 %
15 0.3 % 54 1.7 % +268.58%
Biological Preparations
0.5 %
56 1.3 % 15 0.5 % -72.55%
Research and Development
0.3 %
12 0.3 % 9 0.3 % -21.65%
Leases
0.2 %
4 0.1 % 6 0.2 % +33.38%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
4,214 100.0 % 3,138 100.0 % -25.53%

Managers

Managers TitleAgeSince
Jiu Liang Yan CEO
 Chief Executive Officer 46 01/17/01
Tong Hua Fang FOU
 Founder 61 28/96/28
Lei Wang DFI
 Director of Finance/CFO 43 26/19/26
Pei Bao Lan CHM
 Chairman 51 01/03/01
Zhong Fang Zhang BRD
 Director/Board Member 39 01/12/01
Xue Dong Li BRD
 Director/Board Member 51 01/09/01

Members of the board

Members of the board TitleAgeSince
Yun Qi Zhang BRD
 Director/Board Member 60 17/19/17
Tong Hua Fang FOU
 Founder 61 28/96/28
Pei Bao Lan CHM
 Chairman 51 01/03/01
Xue Dong Li BRD
 Director/Board Member 51 01/09/01
Rui Chao Lin BRD
 Director/Board Member 70 20/21/20
Gong Da Hou BRD
 Director/Board Member 40 19/23/19
Jiu Liang Yan CEO
 Chief Executive Officer 46 01/17/01
Jing Huang BRD
 Director/Board Member 39 01/11/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 941,963,592 222,885,742 ( 23.66 %) 2,697,532 ( 0.2864 %) 23.66 %

Shareholders

NameEquities%Valuation
Fang Tong Hua Family
61.29 %
577,315,294 61.29 % 965 M ¥
Hulin Longpeng Investment Center LP
7.963 %
75,004,720 7.963 % 125 M ¥
Huzhou Saishi Investment Management Co. Ltd.
5.000 %
47,098,180 5.000 % 79 M ¥
Beijing Shengshi Hongming Investment Fund Management Co. Ltd.
2.387 %
22,488,755 2.387 % 38 M ¥
Zuo Wang Li
0.4998 %
4,707,748 0.4998 % 8 M ¥
Yan Xiang Liu
0.4888 %
4,604,258 0.4888 % 8 M ¥
Shenwan Hongyuan Asset Management (Asia) Ltd.
0.4777 %
4,500,104 0.4777 % 8 M ¥
China Southern Asset Management Co., Ltd.
0.4308 %
4,057,835 0.4308 % 7 M ¥
HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD.
0.2718 %
2,560,300 0.2718 % 4 M ¥
Tian Hong Asset Management Co., Ltd.
0.2231 %
2,101,200 0.2231 % 4 M ¥

Holdings

NameEquities%Valuation
HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD.
0.27%
 2,560,300 0.27% 4,281,615 $

Company contact information

HeiLongJiang ZBD Pharmaceutical Co., Ltd.

8 Yantai 1st Road Pingfang District

150060, Harbin

+86 45 8681 1969

http://www.zbdzy.com
address Heilongjiang ZBD Pharmaceutical Co., Ltd.(603567)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD. Stock Heilongjiang ZBD Pharmaceutical Co., Ltd.
+6.91% 166.24Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.35% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 58TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.49% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.15% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+6.19% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.11% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
NOVARTIS AG Stock Novartis AG
+10.02% 21TCr
AMGEN INC. Stock Amgen Inc.
+9.21% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603567 Stock
  4. Company Heilongjiang ZBD Pharmaceutical Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW